[Corotenol, its effectiveness and tolerance in light of new studies].
The effectiveness and tolerance of Corotenol of Mepha Co. was investigated in two studies under conditions of common ambulatory practice of specialists in internal medicine and general practitioners in patients suffering from mild to moderate hypertension and/or ischaemic heart disease. A surprising finding was a high percentage of patients with an inadequately controlled blood pressure before enlistment into the study. During regular check-up examinations already after two weeks a marked reduction or normalization of the blood pressure, was recorded, in the majority of patients. The author assumes that in addition to the effectiveness of the administered drug the marked improvement of the patients is due to better collaboration of the patients and adherence to the prescribed dosage and lifestyle.
Uhlír
O
O
Klinika kardiologie IPVZ, Praha.
D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use; D001262:Atenolol / Q000009:adverse effects / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology
D000959:Antihypertensive Agents; D001262:Atenolol
COROTENOL, jeho úcinnost a snásenlivost ve svĕtle novĕjsích studií.